ORIENTBIO Inc. (002630) — Cash Flow-to-Debt Ratio
ORIENTBIO Inc. (002630) has a Cash Flow-to-Debt Ratio of 0.14x as of December 2025, meaning its operating cash flow of ₩1.77 Billion could theoretically repay 0% of its total liabilities (₩12.64 Billion) in one year. Explore long-term investment intensity of ORIENTBIO Inc. to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ORIENTBIO Inc. Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for ORIENTBIO Inc. across 16 annual periods. Also explore balance sheet size of ORIENTBIO Inc. for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for ORIENTBIO Inc. (2007–2025)
Year-by-year debt coverage analysis for ORIENTBIO Inc.. For market capitalisation and broader financial context, see ORIENTBIO Inc. (002630) total market value.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | ₩752.29 Million | ₩12.94 Billion | ▼ -81.6% |
| 2024 | 0.32x | ₩3.76 Billion | ₩11.89 Billion | ▲ +163.0% |
| 2023 | 0.12x | ₩1.16 Billion | ₩9.66 Billion | ▲ +11.2% |
| 2022 | 0.11x | ₩2.35 Billion | ₩21.76 Billion | ▼ -71.6% |
| 2021 | 0.38x | ₩8.74 Billion | ₩22.97 Billion | ▲ +296.3% |
| 2020 | -0.19x | ₩-3.90 Billion | ₩20.14 Billion | ▲ +64.0% |
| 2019 | -0.54x | ₩-11.54 Billion | ₩21.44 Billion | ▼ -2913.4% |
| 2018 | -0.02x | ₩-1.97 Billion | ₩110.11 Billion | ▲ +73.9% |
| 2017 | -0.07x | ₩-5.11 Billion | ₩74.68 Billion | ▼ -732.3% |
| 2016 | 0.01x | ₩912.43 Million | ₩84.35 Billion | ▼ -45.1% |
| 2015 | 0.02x | ₩1.60 Billion | ₩81.42 Billion | ▼ -29.4% |
| 2014 | 0.03x | ₩2.17 Billion | ₩77.78 Billion | ▼ -59.5% |
| 2013 | 0.07x | ₩5.09 Billion | ₩73.95 Billion | ▼ -57.2% |
| 2011 | 0.16x | ₩3.11 Billion | ₩19.38 Billion | ▼ -26.9% |
| 2010 | 0.22x | ₩9.35 Billion | ₩42.55 Billion | ▲ +305.7% |
| 2007 | 0.05x | ₩1.52 Billion | ₩28.02 Billion | — |